High Blood Cholesterol - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

High Blood Cholesterol > What Your Doctor is Reading About High Blood Cholesterol > Drug Therapy

Drug Therapy

1. Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.

Author: Mackie BD; Satija S; Nell C; Miller J 3rd; Sperling LS;
Institution: Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Journal: Am J Cardiol. 2007 Jan 15;99(2):291. Epub 2006 Nov 27.
Abstract URL: Click here to view abstract

2. Statins and cancer risk.

Author: Karp I; Behlouli H; Lelorier J; Pilote L;
Institution: Department of Social and Preventive Medicine, University of Montreal, Quebec, Canada.
Journal: Am J Med. 2008 Apr;121(4):302-9.
Abstract URL: Click here to view abstract

3. Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia: NICE technology appraisal guidance.

Author: Charles Z; Pugh E; Barnett D;
Institution: National Institute for Health and Clinical Excellence, UK.
Journal: Heart. 2008 May;94(5):642-3.

4. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

Author: Kearney PM; Blackwell L; Collins R; Keech A; Simes J; Peto R; Armitage J; Baigent C; Kearney PM; Blackwell L; Collins R; Keech A; Simes J; Peto R; Armitage J; Baigent C; Kearney PM; Blackwell L; Collins R; Keech A; Simes J; Peto R; Armitage J; Baigent C;
Institution
Journal: Lancet. 2008 Jan 12;371(9607):117-25.
Abstract URL: Click here to view abstract

5. Non-cardiovascular mortality, low-density lipoprotein cholesterol and statins: a meta-regression analysis.

Author: Razzolini R; Tarantini G; Ossena G; Favaretto E; Bilato C; Manzato E; Dalla-Volta S; Iliceto S;
Institution: Department of Cardiology, University of Padova Medical School, Padova, Italy. renato.razzolini@unipd.it
Journal: Cardiology. 2008;109(2):110-6. Epub 2007 Aug 16.
Abstract URL: Click here to view abstract

6. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.

Author: Schwertz DW; Badellino KO;
Institution: College of Nursing, University of Illinois at Chicago, IL 60612, USA. schwertz@uic.edu
Journal: J Cardiovasc Nurs. 2008 Jan-Feb;23(1):8-13.
Abstract URL: Click here to view abstract

7. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.

Author: Mikhailidis DP; Sibbring GC; Ballantyne CM; Davies GM; Catapano AL;
Institution: Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital, Royal Free and University College School of Medicine, London, UK. MIKHAILIDIS@aol.com <MIKHAILIDIS@aol.com>
Journal: Curr Med Res Opin. 2007 Aug;23(8):2009-26.
Abstract URL: Click here to view abstract

8. Effects of once weekly rosuvastatin among patients with a prior statin intolerance.

Author: Backes JM; Moriarty PM; Ruisinger JF; Gibson CA;
Institution: Department of Pharmacy Practice, Kansas University Medical Center, Kansas City, Kansas, USA.
Journal: Am J Cardiol. 2007 Aug 1;100(3):554-5. Epub 2007 Jun 18.
Abstract URL: Click here to view abstract

9. Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia.

Author: Daskalopoulou SS; Mikhailidis DP;
Institution
Journal: Curr Med Res Opin. 2006 Oct;22(10):2037-9.
Abstract URL: Click here to view abstract

10. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

Author: Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE;
Institution: Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA. nichols1@ccf.org
Journal: JAMA. 2007 Feb 7;297(5):499-508.
Abstract URL: Click here to view abstract

11. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.

Author: Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S;
Institution: University of Michigan Department of Internal Medicine, Ann Arbor, MI, USA. paulchan@umich.edu
Journal: Circulation. 2007 May 8;115(18):2398-409. Epub 2007 Apr 23.
Abstract URL: Click here to view abstract

12. One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents.

Author: Ferreira WP; Bertolami MC; Santos SN; Barros MR; de Matos Barretto RB; Pontes SC Jr; Fonseca FH; Carvalho AC;
Institution: Instituto Dante Pazzanese de Cardiologia, Av. Dr. Dante Pazzanese, 500 Bairro Ibirapuera, 04012-180 Sao Paulo, Brazil. wferreir@uol.com.br
Journal: Pediatr Cardiol. 2007 Jan-Feb;28(1):8-13. Epub 2007 Jan 25.
Abstract URL: Click here to view abstract

13. Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients.

Author: Patel AR; Ambrose MS; Duffy GA; Cote H; DeNofrio D;
Institution: Heart Failure and Cardiac Transplant Center, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA. apatel@tufts-nemc.org
Journal: J Heart Lung Transplant. 2007 Mar;26(3):281-4.
Abstract URL: Click here to view abstract

14. Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.

Author: Tajima N; Kurata H; Nakaya N; Mizuno K; Ohashi Y; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
Institution: Department of Internal Medicine, Jikei University School of Medicine 3-25-8, Nishi-Shimbashi, Minato-ku, 105-8461 Tokyo, Japan. ntajima@jikei.ac.jp
Journal: Atherosclerosis. 2008 Aug;199(2):455-62. Epub 2008 May 28.
Abstract URL: Click here to view abstract

15. Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs.

Author: Wei L; Murphy MJ; MacDonald TM;
Institution: Health Informatics Centre, Division of Community Health Sciences, University of Dundee, Dundee, UK.
Journal: Heart. 2006 Jun;92(6):746-51. Epub 2005 Oct 10.
Abstract URL: Click here to view abstract

16. Statin-related adverse events: a meta-analysis.

Author: Silva MA; Swanson AC; Gandhi PJ; Tataronis GR;
Institution: Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA. msilva@wor.mcphs.edu
Journal: Clin Ther. 2006 Jan;28(1):26-35.
Abstract URL: Click here to view abstract

17. Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.

Author: Rosenson RS;
Institution: Preventive Cardiology Center, Northwestern University, Chicago, IL, USA. r-rosenson@northwestern.edu
Journal: Am Heart J. 2006 Mar;151(3):556-63.
Abstract URL: Click here to view abstract

18. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.

Author: Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y;
Institution: Miami Research Associates, Coral Gables, Florida 33146, USA. tfeldmanmd@aol.com
Journal: Clin Ther. 2006 Jun;28(6):849-59.
Abstract URL: Click here to view abstract

19. The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia.

Author: Ozaki K; Kubo T; Imaki R; Shinagawa H; Fukaya H; Ohtaki K; Ozaki S; Izumi T; Aizawa Y;
Institution: Division of Cardiology, Niigata University Graduate School of Medical & Dental Sciences, Niigata, Japan. k-ozaki@hosp.niigata.niigata.jp
Journal: J Atheroscler Thromb. 2006 Aug;13(4):216-9.
Abstract URL: Click here to view abstract

20. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.

Author: Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y;
Institution: Lipid Clinic, Medical Department, Rikshospitalet, Oslo, Norway. leiv.ose@klinmed.uio.no
Journal: Curr Med Res Opin. 2006 May;22(5):823-35.
Abstract URL: Click here to view abstract